CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 278 enrolled
Drug / intervention
BC/ egg +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03801317
NCT03801317N/ACompleted

The Effect of Bovine Colostrum/ Egg Supplementation in Young Malawian Children

Washington University School of Medicine·interventional·Posted Jan 11, 2019·Updated Sep 16, 2020

In Brief

A clinical study evaluating BC/ egg, Control, and 1 other intervention for Stunting and Environmental Enteric Dysfunction. Completed, enrolled 278 participants across 1 site.

Detailed Summary

The trial will consist of adding either a supplement of 4.3g egg powder + 5.7g bovine colostrum or a control flour along with a multiple micronutrient powder to the diets of healthy Malawian children 9 months of age. This supplement provides additional essential amino acids, choline and immunoactive colostrum. Children will be receive either the supplement or control for 12 weeks. Children will have regular follow-up where anthropometry is measured. At enrollment and after 12 weeks, stool will be collected and a urinary lactulose permeability test conducted. Children will be measured at enrollment and at weeks 2, 4, 8, 12, 20, 32 after enrollment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesMalawi

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJan 11, 2019
Enrollment StartDec 3, 2018
Primary CompletionDec 30, 2019
Study CompletionMay 30, 2020
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 7.5 years ago

Interventions

BC/ eggdietary

4.3 egg powder + 5.7 g bovine colostrum

Controldietary

15 grams corn-soya blend

multiple micronutrientdietary

multiple micronutrient sprinkle powder